Clinical trial
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
NCT02488720 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
- Lead sponsor
- University of Southern California
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 8, 2015
- Completion date
- September 29, 2023
- Enrollment
- 538 (actual)
- Sites
- 40
Conditions
As the registry lists them; a condition with its own page is linked.